Kairos Capital Management is a fund manager in Rye with $605.69 mm assets under management.
Company profile
Website
Employees
Incorporated
Fiscal year end
Industry
SEC CIK
IRS number
843799363
SEC advisor number
801-119993
FINRA CRD number
310191
AUM ?
$605.69 mm
(as of 27 Apr 23)
Accounts
10
(as of 27 Apr 23)
Employees
9
(5 investment advisory or research)
Office hours
Monday - Friday, 9-5
Ownership
Owner | Title | From | %Ownership |
---|---|---|---|
Toussi, Sina | Limited Partner / Chief Investment Officer | 12/2019 | 50-75% |
Two Seas Capital GP LLC | General Partner | 10/2019 | < 5% |
Toussi, Sina | Member | 10/2019 | > 75% |
Palermo, Lawrence, Vincent | Chief Compliance Officer / Chief Financial Officer | 11/2020 | 5-10% |
Bennett, John, Patrick | Managing Director / Head Trader | 03/2021 | 5-10% |
Sheth, Himanshu, Dipak | Managing Director / Head of Research | 03/2021 | 10-25% |
Chasen, David, Scott | Managing Director | 03/2021 | 5-10% |
Ownership
Fund structure | AUM | Fund type |
---|---|---|
Two Seas Capital LP | $605.69 mm | |
Two Seas Duration Litigation Opportunities Fund LLC - Class 1 | $2.54 mm | Hedge Fund |
Two Seas Duration Litigation Opportunities Fund LLC - Class 3 | $3.94 mm | Hedge Fund |
Two Seas Duration Litigation Opportunities Fund LLC - Class 4 | $1.51 mm | Hedge Fund |
Two Seas Global (Master) Fund LP | $279.14 mm | Hedge Fund |
Two Seas Global (Domestic) Fund LP | $90.94 mm | Hedge Fund |
Two Seas Global (Cayman) Fund LP | $40.37 mm | Hedge Fund |
Two Seas Litigation Opportunities Fund LLC | $272.64 mm | Hedge Fund |
Two Seas LNP Opportunities (Master) Fund LP | $39.94 mm | Hedge Fund |
Two Seas LNP Opportunities (Cayman) Fund LP | $6.99 mm | Hedge Fund |
Two Seas LNP Opportunities (Domestic) Fund LP | $28.58 mm | Hedge Fund |
Latest filings (excl ownership)
Latest ownership filings
13F-HR
Quarterly holdings report by institutional manager
14 Aug 24
SC 13D/A
INDIVIOR PLC
21 Jun 24
13F-HR
Quarterly holdings report by institutional manager
15 May 24
SC 13D/A
INDIVIOR PLC
29 Mar 24
SC 13G/A
Esperion Therapeutics, Inc.
14 Feb 24
SC 13G/A
Arbutus Biopharma Corp
14 Feb 24
SC 13G/A
ODYSSEY MARINE EXPLORATION INC
14 Feb 24
13F-HR
Quarterly holdings report by institutional manager
14 Feb 24
SC 13G
Arbutus Biopharma Corp
21 Nov 23
13F-HR
Quarterly holdings report by institutional manager
14 Nov 23